logo

Moog Inc.

Q22022

4/29/2022

speaker
Operator

Welcome to the Mohs fiscal year 2022 second quarter earnings conference call. Today's conference is being recorded. At this time, I would like to hand the conference to Ann Lohr. Please go ahead.

speaker
Ann Lohr
Vice President, Investor Relations

Good morning. Before we begin, we call your attention to the fact that we may make forward-looking statements during the course of this conference call. These forward-looking statements are not guarantees of our future performance and are subject to risks, uncertainties, and other factors. that could cause actual performance to differ materially from such statements. A description of these risks, uncertainties, and other factors is contained in our news release of April 29, 2022, our most recent form, 8K, filed on April 29, 2022, and in certain of our other public filings with the SEC. We've provided some financial schedules to help our listeners better follow along with the prepared comments. For those of you who do not already have a copy of the document, A copy of today's financial presentation is available on our investor relations webcast page at www.mo.com. John?

speaker
John Scannell
Chairman and Chief Executive Officer

Thanks, Anne. Good morning. Thanks for joining us. This morning we'll report on the second quarter of fiscal 22 and affirm our guidance for the remainder of the year. Let me start with the key financials. It was a strong quarter with adjusted earnings per share of $1.49, 12% higher than the adjusted $1.33, we recorded in Q2 fiscal 21. Adjusted EPS this quarter was also slightly above the high end of our guidance from 90 days ago. The situation around COVID and supply chain disruption continued to present challenges during the quarter, but our teams managed these well. Adjusted free cash flow in the quarter, excluding the impact of our securitization facility, was negative 24 million. Finally, there's no change to our guidance for the full year. Full year sales will be $3 billion, with adjusted earnings per share of $5.50 plus or minus 20 cents. Now let me move to the headlines. First, the world has changed considerably since we reported our Q1 earnings at the end of January. The Russian invasion of Ukraine has reset expectations around long-term defense spending, particularly in Europe. At this stage, the impact on our overall defense business is difficult to estimate. We believe, however, that there will be no material change over the next six months, which potential tailwinds in future fiscal years. Second, COVID, supply chain, labor attrition, and inflation continue to weigh on economic activity and make short-term financial forecasting difficult. To date, we've managed well through these challenges, as evidenced by our results this quarter. However, they will continue to be major distractions to normal business operations throughout the remainder of this fiscal year. Third, we took charges this quarter across our segments tied to the delayed recovery in the commercial aircraft business, the Russian actions in Ukraine, and further refinements in our portfolio. The total charges had an adverse impact on earnings per share of 59 cents in the quarter. I'll provide more details on each of the charges as I move through the segment discussions. And finally, we're pleased with the results of our second quarter, which came in ahead of forecast. 90 days ago, our plan for the year included a considerable ramp up in earnings in the second half. The underlying outlook for the year has not changed. Rather, some of the forecasted Q3 and Q4 earnings increase actually accelerated into the second quarter. As a result of the stronger Q2, we're now forecasting Q3 and Q4 to be pretty much in line with Q2 both in terms of sales and earnings. Now let me move to the details, starting with the second quarter results. Sales in the quarter of $771 million were 5% higher than last year. We saw increases in each of our three operating groups. Taking a look at the P&L, we incurred a $2 million charge as we wrote down some inventory and receivables associated with exiting our activities with Russia. Despite this charge, our gross margin was up slightly on the higher sales and a better mix. R&D and SG&A expenses were more or less in line with last year as a percentage of sales. We incurred restructuring costs of $8 million in the quarter, as well as an impairment charge of $15 million. Both charges were associated with resizing the business and continuing our portfolio shaping activities. Interest expense was slightly lower than last year. The effective tax rate this quarter was 24.9%, resulting in GAAP net earnings of 29 million and GAAP earnings per share of 91 cents. In order to compare the underlying operating performance with Q2 last year, there are adjustments we need to make to each quarter. In Q2 fiscal 21, we recorded an 18-cent gain on a pension curtailment in Europe. Excluding this gain, the adjusted net earnings last year were $43 million, and the adjusted EPS was $1.33. This year, in Q2, we incurred the inventory write-down, restructuring, and impairment charge in the quarter. Excluding the impact of these one-time charges in Q2 fiscal 22, our net earnings this year were $48 million, and our earnings per share were $1.49. On an adjusted basis, net earnings and earnings per share were both up 12% over the same quarter last year. This is 22 outlook. Our full year outlook remains unchanged from 90 days ago. We're forecasting sales of $3 billion of 6% from last year and adjusted earnings per share of 550 of 13%. We anticipate a slight acceleration in earnings in the second half. We're keeping our full year EPS range unchanged at plus or minus 20 cents to reflect the continued uncertainty in the global economic climate particularly in relation to the supply chain. Now to the segments. I'd remind our listeners that we provided a four-page supplemental data package posted on our webcast site, which provides all the detailed numbers for your models. We suggest you follow this in parallel with the text. Beginning with aircraft. Our aircraft business provides flight control products to two very distinct markets, each with their own macroeconomic drivers. On the military side, the Russian invasion of Ukraine has changed the narrative around defense spending. In the U.S., both sides of the aisle are aligned on the importance of strong defense spending, while the European nations are redefining their level of commitment to defense budgets. The impact of these shifts on our business will play out over many years to come, although we don't believe there will be any material impact in the present fiscal year. On the commercial side, the overall atmosphere continues to improve, with U.S. airlines showing stronger results and projecting further growth over the coming months. Aftermarket activity is on the rise, and we're seeing this filter through in our numbers. On the other hand, the recent crash of a 737 in China, the continued delay in resuming 787 deliveries, and the decision by Airbus to temper the future ramp on the A350 are weighing on the longer-term outlook for our business. China's new front in their battle with COVID and the risk of recession in Europe arising from the Ukrainian conflict are also items we're watching. On balance, we remain bullish about the commercial business, but believe the recovery to pre-pandemic activities continues to move to the right. This shift in our longer term view of the commercial OEM recovery drove us to take further actions in the second quarter to resize the business. Back in 2020, we made a significant adjustment to our commercial workforce and incurred impairment charges as a result of the pandemic. At that time, The level of adjustment was based on our internal model of when we would see a recovery in the commercial business. Our intention was to ensure we had sufficient labor and capital to respond to the increase in production rates the OEMs were forecasting. The delays in expected volume recovery at our major customers made it clear that we needed to make further adjustments to our staffing and asset base this quarter. As a result, we incurred $15 million of impairment charges and $4 million of restructuring charges in the quarter. Aircraft Q2. Sales in the quarter of $311 million were 2% higher than last year. This quarter, our growth came from the aftermarket, both on the military and commercial side. Military aftermarket sales were up nicely, with growth across a broad range of programs. We saw particular strength on the V-22 and F-15 platforms. In contrast, our military OEM sales were down from a year ago. The largest component of this drop was lower F-35 sales, driven mostly by the timing of material receipts. We also saw lower foreign military sales compensated by higher B-22 activity. In last year's second quarter, we had $5 million of sales from our navigation aids business. You may remember we divested this business in Q1 this year, further driving the negative sales comparison with a year ago. On the commercial side, OEM sales were about flash with last year, Lower 787 sales were compensated primarily by higher business jet sales, as well as slightly higher activity on the 737 and A350 programs. We are keeping the OEM production rates on our major programs fairly steady internally in order to maintain the health of our supply chain and the efficiency of our plants. Therefore, the fluctuation in sales numbers from quarter to quarter is less a reflection of internal production volatility and more the impact of the timing of material receipts. Commercial aftermarket sales were way up this quarter. This is a combination of two items, underlying strength in the book of business and some one-time activities that booked this quarter. Each of these items contributed about half of the growth in the quarter. The underlying business continues to surprise to the upside with increases across all major platforms. The 787 continued to lead the way as international travel recovers. We also benefited from seven one-time items in the quarter, including some test equipment sales. These items will not repeat in future quarters. Aircraft margins. Gap operating margins in the quarter of 4% included 600 basis points of headwind from the resizing activities I've described. Adjusted operating margins of 10.0% were up nicely from the same quarter a year ago and also from our first quarter. The strength in the aftermarket on both the military and commercial sides of the house drove the margin gain. Aircraft fiscal 22. We're keeping our full-year sales forecast unchanged from 90 days ago at $1.25 billion, up 7% from fiscal 21. However, we're adjusting the mix between military and commercial based on the experience of the first half. In total, military sales would be marginally lower than our previous forecast, while commercial sales would be marginally higher. We're keeping our full year adjusted margin forecast unchanged at 10.1%. This implies a strengthening from the run rate of the first half. We've already seen a nice margin pick up from the second quarter. I believe we will see some further improvements as we move through the next two quarters. Turning now to space and defense. Similar to last quarter, underlying demand in both our space and defense markets remain strong. The shift in the global defense posture over the last 90 days should ensure our business in both markets remains strong for years to come. While our space portfolio has growth opportunities in both commercial and defense-related markets, our present book of business is dominated by U.S. government contracts. Therefore, increases in future defense spending and the emphasis on space as the next frontier in any future conflict bode well for our business. In other news, we concluded some portfolio refinement this quarter and incurred a $2 million charge. Space and defense Q2. Sales in the quarter of $223 million were 8% higher than last year. Both the space and defense portfolios are driving growth in this business, with the lead passing from one market to the other from one quarter to the next. This quarter, it was the defense side of the house that drove the growth. Defense sales were up 15%, driven by strong growth on our RIP shore ad program. Sales of missile applications were down marginally, compensated by slightly higher component sales. On the space side, growth in our space vehicles business compensated for lower hypersonic activity and slightly softer sales across a range of our heritage components businesses. As I mentioned last quarter, our hypersonic development activity is winding down, and we will have a period of lower activity as the government decides which programs to move forward to the next phase of development and production. Space and defense margins. Gap margins of 10.8% included 80 basis points of portfolio refinement charges. Adjusted margins of 11.6% were up from our first quarter results and are in line with our forecast for the full year. Space and defense fiscal 22. There's no change to our sales forecast for the full year. Full year space sales of $350 million assume a second half in line with the first. Full year defense sales of $530 million assume a slight acceleration in the run rate as both our missile and components portfolios grow. For the full year, we're keeping our adjusted margin forecast unchanged at 11.5%, slightly better than the performance of the first half. Turning now to our industrial systems business. Underlying demand for industrial products was strong over the last quarter. Higher energy prices, increased pilot training, and the general demand for automation equipment to expand production capacity bode well for continued strength in our business over the next few quarters. Growth across the industrial world remains healthy, although COVID spikes, particularly in China, and geopolitical events in Europe have increased the risk of an economic slowdown next year. The direct impact of the Russian actions in Ukraine show up in our industrial segments. Very soon after the invasion, we made the decision to cease all business with Russia. Our ongoing sales into Russia were small, so there's no material impact to our outlook for the year. However, this decision, combined with some minor portfolio refinements across the footprint, resulted in a $4 million hit to earnings in the quarter, just over half associated with Russian charges and the remainder portfolio shaping. Industrial systems Q2, sales in the quarter of $236 million were 5% higher than last year. Excluding the impact of foreign exchange movements and lost sales from portfolio shaping activities, underlying sales were up over 10% organically. Simulation test sales were way up on increased flight simulation activity. Sales into the sub-market almost doubled from a year ago. It would appear that flight training activity is finally recovering from the pandemic slowdown. Energy sales were up on higher generation and exploration activity. Industrial automation sales were about flat, but adjusting for portfolio shaping and our organic sales into this market were up mid single digits over last year. Finally, sales into medical markets were down slightly on lower component sales for ventilator applications. On a positive note, across the portfolio, our bookings continue to be strong and our backlog is growing. Our challenge, is meeting the demand from our customers given the supply chain constraints. Industrial margins. Gap margins in the quarter of 8.8% include 170 basis points of restructuring and impairment charges. Adjusted margins of 10.5% were in line with last year and up nicely from the first quarter. In Q1, we incurred some production disruption and moving expenses as we consolidated facilities in Europe and the U.S. Industrial fiscal 22. There's no change to our sales forecast from last quarter. For the full year, we anticipate sales of $910 million. This total assumes a modest pickup in the second half as we work to accelerate shipments to meet customer demand. Our full year forecast for adjusted margins is also unchanged at 9.5%. This margin is slightly ahead of the run rate of the first half. So, in summary... It was a good quarter overall, with adjusted earnings per share above our forecast from 90 days ago. We saw an acceleration of some planned earnings upside later in the year into the second quarter, so that our overall forecast for the year remains unchanged at $5.50 plus or minus $0.20. This full year forecast assumes a second half performance slightly ahead of the first half, but in line with the second quarter, both in terms of sales and margins. Cash flow in the quarter was soft, but this should recover in the second half. As we look to the next six months, there are both risks to our plan as well as opportunities to do better. On the risk side, an escalation of hostilities in Ukraine or a spread to other parts of Europe could materially change the outlook. Also, further aggressive lockdowns in China as they fight the Omicron variant could exacerbate the supply chain challenges and slow overall economic growth. On the opportunity side, the rebound in global travel could drive further commercial aircraft aftermarket upside, and an easing of supply chain constraints could provide the opportunity to accelerate sales in each of our operating groups to meet customer demand. As always, we try to weigh the possibilities of both upside opportunities and downside risks, and provide the market with our best estimate of the outcome. Overall, our business remains very healthy, and we believe there are many opportunities to see continued growth in both sales and margins over the years to come. For the third quarter, we anticipate earnings per share of $1.45 minus 15 cents. Our range continues to be relatively wide due to the uncertainties in global economic conditions. Despite these uncertainties, our backlog is strong and our outlook remains bullish. Now, let me pass you to Jennifer, who will provide more color on our cash flow and balance sheet.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-